View Older Stories

Dec 1, 2025 05:08AM RBC Capital Upgrades Neumora Therapeutics (NMRA) to Outperform

Nov 17, 2025 04:24AM Neumora Therapeutics (NMRA) PT Raised to $3 at Stifel

Nov 6, 2025 08:19AM Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 10c

Oct 27, 2025 07:57AM Guggenheim Upgrades Neumora Therapeutics (NMRA) to Buy

Oct 27, 2025 06:30AM Neumora reports weight loss results for NMRA-215 in preclinical studies

Oct 23, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Sep 15, 2025 04:41PM JPMorgan Downgrades Neumora Therapeutics (NMRA) to Underweight

Aug 7, 2025 10:00AM Stifel on Neumora Therapeutics (NMRA): ' it's hard to have much conviction in the mechanism in MDD'

Aug 6, 2025 05:09PM Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 12c

Jul 16, 2025 05:52AM Neumora Therapeutics (NMRA) PT Raised to $5 at Mizuho

Jul 10, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Jul 9, 2025 07:03AM Neumora begins phase 1 trial of schizophrenia drug NMRA-861

May 13, 2025 07:05AM Neumora Therapeutics, Inc. (NMRA) Tops Q1 EPS by 4c

Apr 29, 2025 07:28AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Apr 16, 2025 01:02PM Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm

Apr 7, 2025 12:55PM FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Apr 5, 2025 01:11PM NMRA IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securit

Apr 4, 2025 12:35PM NMRA FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securiti

Apr 3, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Apr 2, 2025 04:04PM NMRA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class A

Apr 2, 2025 01:38AM Deutsche Bank Downgrades H Lundbeck A/S (HLUNB:DC) (HLUYY) to Hold

Apr 2, 2025 01:10AM BofA Securities Downgrades Neumora Therapeutics (NMRA) to Underperform

Apr 1, 2025 08:35PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Apr 1, 2025 01:55PM NMRA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action Commenced by the Firm - NMRA

Mar 31, 2025 08:30PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 29, 2025 04:32PM NMRA FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by

Mar 28, 2025 04:32PM NMRA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Fir

Mar 28, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 27, 2025 04:27PM NMRA DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Fi

Mar 27, 2025 11:18AM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 26, 2025 04:22PM NMRA DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the

Mar 24, 2025 04:13PM ROSEN, A TOP RANKED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 23, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 23, 2025 02:02PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 22, 2025 12:23PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 21, 2025 12:18PM ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 19, 2025 07:07PM ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 18, 2025 07:02PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 17, 2025 06:56PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 17, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 17, 2025 02:27PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 16, 2025 06:57PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 15, 2025 06:57PM ROSEN, A TOP RANKED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 14, 2025 06:52PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 11, 2025 09:40PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 11, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 10, 2025 05:18PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 10, 2025 01:44PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 10, 2025 07:24AM William Blair Downgrades Neumora Therapeutics (NMRA) to Market Perform

Mar 10, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

View Older Stories